Evaluation of Ion Releasing Hybrid Restorative Material
NCT ID: NCT04854655
Last Updated: 2021-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
45 participants
INTERVENTIONAL
2021-10-10
2022-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Short Fiber Reinforced Resin Composite Versus Indirect Nanohybrid Resin Composite Onlay Restorations.
NCT03283280
Evaluation of a New Bioactive Material Versus a Fluoride-Releasing Hybrid Restorative Material in Cervical Lesions
NCT05149209
Clinical Assessment of Giomer Based Technology Versus Smart Bioactive Restoration in Carious Class V Cavities
NCT05466461
Reminerlization Potential of Innovative Biomimetic Material in Caries White Spot Lesions
NCT03823612
Evaluation of Marginal Integrity Using Bioactive Cement Incementation of Indirect Composite Blocks
NCT04557657
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Conventional resin composite
Conventional resin composite
nanofilled resin composite
Intervention 1
Activa Presto
Activa Presto
calcium and phosphate hybrid material
Intervention 2
Giomer
Giomer
fluoride releasing hybrid material
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conventional resin composite
nanofilled resin composite
Activa Presto
calcium and phosphate hybrid material
Giomer
fluoride releasing hybrid material
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients consulting in one of the outpatient clinics listed above.
* Patients can tolerate necessary restorative procedures.
* Provide informed consent.
* Patients accept the one year follow-up period.
* Patients are within middle age group (25-40years).
* Cooperative patients.
* Patients don't have any medically compromised conditions.
Tooth related criteria:
* Teeth with primary proximal carious lesions in posterior teeth with no pulpal involvement.
* Teeth should have contact with the adjacent teeth.
* Teeth are vital according to pulp-sensitivity tests.
* No active gingival or periodontal conditions.
Exclusion Criteria
* Pregnant women; as radiographs are prohibited.
* Allergic Patients to any of the restorative materials, including anesthetics.
* Uncooperative patients will not follow the instructions or attend the appointments.
Tooth related criteria:
* Retained deciduous teeth; as the research is targeting only permanent teeth.
* Teeth with previous restorations, which may add another variable to the study (type of old restorative material, extent of recurrent caries).
* Spontaneous pain or prolonged pain after sensitivity tests (cold and electrical tests) indicating irreversible pulpitis.
* Negative sensitivity tests, periapical radiolucencies, and sensitivity to axial or lateral percussion indicating pulp necrosis.
* Teeth presenting external or internal resorption, with adverse pulpal reactions which may affect the outcome of the study.
* Teeth with cervical caries; which can't be evaluated on periapical radiographs.
25 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nouran Osama El-Sayed Ahmed Abou El-Nour
Resident at Faculty of Dentistry
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1994
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.